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With its high mutation rate, HIV is capable of escape from recognition, suppression and/or killing by
CD8þ cytotoxic T lymphocytes (CTLs). The rate at which escape variants replace each other can give
insights into the selective pressure imposed by single CTL clones. We investigate the effects of specific
characteristics of the HIV life cycle on the dynamics of immune escape. First, it has been found that
cells in HIV-infected patients can carry multiple copies of proviruses. To investigate how this process
affects the emergence of immune escape, we develop a mathematical model of HIV dynamics with mul-
tiple infections of cells. Increasing the frequency of multiple-infected cells delays the appearance of
immune escape variants, slows down the rate at which they replace the wild-type variant and can even
prevent escape variants from taking over the quasi-species. Second, we study the effect of the intracellular
eclipse phase on the rate of escape and show that escape rates are expected to be slower than previously
anticipated. In summary, slow escape rates do not necessarily imply inefficient CTL-mediated killing of
HIV-infected cells, but are at least partly a result of the specific characteristics of the viral life cycle.
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mathematical model1. INTRODUCTION
Cytotoxic T lymphocytes (CTLs) are thought to impose a
strong selection pressure on HIV replication through kill-
ing and/or suppression of virus-infected cells [1–3].
Owing to the high mutation rate of HIV, the virus can
acquire immune escape mutations and frequently evades
recognition from CTLs during the first months of
the infection [4–6]. Analysing longitudinal data on the
evolution of immune escape variants can give insights
into the selective pressure that is induced by the CTLs.
The rate at which an escape variant replaces the wild-
type virus reflects the difference in the net replication
rate of the two variants. Because the escape variant is con-
sidered to have evaded the killing induced by a specific
CTL clone, the ‘escape rate’ has been related to the
rate at which the infected cells were killed by specific
CTLs. Asquith et al. [7] have analysed a large dataset
of longitudinal data on immune escape and generally
found slow escape rates which suggested that CTL-
mediated killing of infected cells is inefficient. However,
interpreting the data of immune escape is challenging
and critically depends on the underlying assumptions of
how immune escape variants replace the wild-type virus
[8,9]. CTLs definitely impose a very strong selection
pressure on HIV during acute infection as several
escape variants replace each other very rapidly during
the first months of infection [4,5]. During chronic HIV
infection, the relation between CTL-mediated killing,
immune escape and viral control is less clear [10].
Specific characteristics of the HIV replication life cycle
are likely to influence the dynamics of immune escape.r for correspondence (christian.althaus@alumni.ethz.ch).
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14 March 2012 3003First, it was found that 75–80% of HIV-infected cells in
the spleen harbour more than one provirus [11]. This
observation has led to a series of mathematical models
to study the influence of multiple-infected cells during
HIV infection. Mathematical and population genetic
models have given important insights into the evolution
of drug-resistant variants [12–15]. Others have analysed
the process of multiple infection and how it affects the
viral dynamics within a host [16–18]. More recently,
it has been found that the majority of HIV-infected
CD4þ T cells from peripheral blood contain only a
single provirus [19]. Low frequencies of multiple-infected
cells are also suggested by two modelling studies that con-
clude that only 10 per cent of HIV-infected cells are
multiply infected [20,21]. Nevertheless, it remains impor-
tant to study the effects of multiple-infected cells on
immune escape. One intriguing aspect of multiple-
infected cells has already been noted in the study by
Jung et al. [11], namely that ‘mutation in an epitope
that is encoded by one provirus would still leave the cell
vulnerable to recognition of the same epitope encoded
by the other proviruses’. To our knowledge, there is
only one study to date that investigates the evolutionary
dynamics of CTL escape mutants when cells can be mul-
tiply infected with HIV. Wodarz & Levy [22] have shown
that in the context of co-infection, an intermediate
strength of CTL response is most detrimental to an
escape mutant, minimizing the overall virus load. How-
ever, it remains unclear how multiple-infected cells
affect the emergence of escape variants and the rate of
replacement of wild-type virus. A second important
characteristic of the HIV life cycle is the intracellular
eclipse phase, i.e. the delay of an infected cell before itThis journal is q 2012 The Royal Society
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Figure 1. Illustration of multiple infections of cells with HIV.
Uninfected target cells, T, can either become infected with
wild-type virus (Vw) or the escape variant (Ve). A secondary
infection of a single-infected cell with another virus results in
a double-infected cell. The single- and double-infected cells,
S and D with their corresponding indices, respectively,
produce wild-type (filled circles) and escape variant virus
(open circles). Cytotoxic T lymphocyte (CTL)-mediated
killing only targets the cells that produce wild-type virus
(grey cells). Death rates of cells and virus production and
clearance rates are not shown.
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has been shown to influence dynamical aspects of virus
growth and HIV replication [24] but it has been generally
neglected in the studies of immune escape. In order to
obtain a more detailed view of immune escape, it is there-
fore critically important to investigate the influence of
the properties of the HIV life cycle.
In this study, we devise a new mathematical model of
HIV dynamics with multiple-infected cells in order to
study the time at which CTL escape variants appear,
and the rate at which they replace the wild-type variant.
Additionally, we investigate how the intracellular eclipse
phase affects the escape rate of HIV. In both cases, we
find that these assumptions can alter the rate of
immune escape, which has important implications on
the quantitative aspects of CTL-mediated killing of
HIV-infected cells.2. MODEL
(a) Multiple infections of cells
We devise a mathematical model of HIV dynamics that is
based on standard models of within-host virus dynamics
[25,26]. To account for multiple infections of cells,
single-infected cells can get infected by a second viral
particle to become a double-infected cell (figure 1):
dT
dt
¼ l bVwT  b0VeT  dTT ; ð2:1Þ
dSw
dt
¼ bVwT  rVwSw  r 0VeSw  ðdþ kÞSw; ð2:2Þ
dSe
dt
¼ b0VeT  r 0VeSe  rVwSe  dSe; ð2:3Þ
dDww
dt
¼ rVwSw  ðdþ kÞDww; ð2:4Þ
dDwe
dt
¼ rVwSe þ r0VeSw  ðdþ kÞDwe; ð2:5ÞProc. R. Soc. B (2012)dDee
dt
¼ r0VeSe  dDee; ð2:6Þ
dVw
dt
¼ p Sw þDww þDwe
2
 
 dVVw ð2:7Þ
and
dVe
dt
¼ p Se þDee þDwe
2
 
 dVVe: ð2:8Þ
Non-infected CD4þ target cells T are produced at a
rate of l cells per day and die at rate dT. They can
become infected with either the wild-type virus, Vw, at
rate b or the escape variant, Ve, at rate b
0. We define
b0 ¼ b(1 2 c) to account for a potential fitness cost of
the escape variant. After a cell has been infected with a
single virus (Sw and Se), it can become double-infected
with wild-type or escape virus at rate r or r 0, respectively.
Again, we set r 0¼ r(1 2 c) to account for a potential
fitness cost of the escape variant. The resulting double-
infected cells are either infected with the same virus
(Dww and Dee) or infected with the wild-type and the
escape variant (Dwe). To account for different frequencies
of multiple-infected cells, we will vary the secondary
infection rate r. We define f as the fraction of multiple-
infected cells when the infection has approached the
chronic steady-state in the absence of an escape variant,
i.e. f ¼ Dww /(Sw þ Dww). The secondary infection rate r
can then be expressed as a function of f in the interval
of [0,1), i.e. any desired fraction of multiple-infected
cells can be obtained by setting r as
r ¼ fbdVðdþ kÞ
2
ð f  1ÞðdTdVðdþ kÞ  pblÞ : ð2:9Þ
Wild-type and escape virus are produced by their corre-
sponding cells with rate p per day and cleared at rate dV
per day. The production of cells that are doubly infected
with both variants is divided into one-half for each. This
presumes that the amount of virus production is deter-
mined by the cell and not by the number of integrated
proviruses. It also ensures that increasing the fraction of
multiple-infected cells does not change the set point
viral load during the chronic phase of infection. Cells
that produce wild-type virus will additionally be killed
by a specific CTL clone at a rate k per day. We also
include mutation in our model but for better clarity it is
not shown in the equations. Shortly, mutation happens
upon infection and is included in all infection terms.
For example, if a target cell, T, becomes infected with
wild-type virus Vw, then a small fraction mutates into
an escape variant (mbVwT ), whereas the majority remains
wild-type ((12 m)bVwT ). The parameters for the model
are given in table 1.(b) Intracellular delay
Additionally, we devise a model of virus dynamics to
study the effects of an intracellular delay on the rate of
immune escape. As the escape variant competes with
the wild-type virus on the same resource, i.e. the CD4þ
target cells, they replace each other at a rate that is
given by the difference between their corresponding net
growth rates. In order to derive an analytical solution of
the ‘escape rate’, we simplify the description of HIV
dynamics into cells that are infected with either the
Table 1. Parameter values for the HIV dynamics model with multiple infections.
parameter value explanation and reference
l 3  107 cells d21 tuned to obtain a total number of 107–108 infected cells [27,28].
dT 0.1 d
21 natural death rate of CD4þ target cells T.
b 1  10210 d21 infection rate per virus particle. Results in an initial viral growth rate of 1.5 d21 [29].
d þ k 1.0 d21 maximal death rate of virus-producing cells [16,24,30].
p 2300 d21 virus production rate [31].
dV 23 d
21 clearance rate of viral particles [32].
m 3  1025 HIV-1 mutation rate per nucleotide [33].
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dIw
dt
¼ bPw  gIw  dIIw  kIIw; ð2:10Þ
dPw
dt
¼ gIw  dPPw  kPPw; ð2:11Þ
dIe
dt
¼ bPe  gIe  dIIe ð2:12Þ
and
dPe
dt
¼ gIe  dPPe: ð2:13Þ
Infected cells, Iw and Ie, move through an intracellular
eclipse phase with rate g per day to become virus-producing
cells, Pw and Pw. This is a linear model because we have
excluded an equation for target cells like the one given in
equation (2.1). New infected cells are ‘produced’ at a
per capita rate b proportional to the number of virus-
producing cells, i.e. the equation for the virus particles has
been removed by a quasi-steady-state assumption [9]. The
infected cells during the eclipse phase are subject to a
death rate dI, and the cells infected with wild-type virus are
additionally killed by CTLs at a rate kI. Virus-producing
cells die at rate dP and, provided that they producewild-type
virus, they are killed at rate kP.
We now define R as the ratio of the escape variant over
the wild-type variant. Because we do not explicitly con-
sider the virus populations, we simply take the ratio of
the virus-producing cells, i.e. R ¼ Pe=Pw. The rate r at
which the ratio of the two variants is changing during
the replacement corresponds to the escape rate, i.e. the
difference in the net growth rate of the two variants
dR
dt
¼ rR: ð2:14Þ
In our two-stage model, it is not straightforward to
express the time derivative of the ratio as a function of
R alone. We therefore simplify by assuming that the
wild-type population has approached equilibrium, i.e.
dIw=dt ¼ 0 and dPw=dt ¼ 0, and consider the invasion
of the escape mutant. Additionally, we assume that
during the invasion of the escape variant, the ratio of
the infected cells over the virus-producing cells, Ie=Pe, is
approaching quasi-steady-state, i.e. we assume dðIe=PeÞ=
dt ¼ 0 [34]. These assumptions allows us to express the
‘infection rate’ b as a function of the other parameters
b ¼ ðdI þ kI þ gÞðdP þ kPÞ
g
; ð2:15Þ
and provide steady-state values for Iw and Ie (not shown).
Substituting these three expressions into equation (2.14),
using the quotient rule of differentiation, and solving for
r, it can be shown that if an escape variant invades theProc. R. Soc. B (2012)wild-type population, then it will replace the wild-type
at a rate given by
r ¼ 1
2
 
+
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðdI þ dP þ gÞ2 þ 4ðkIdP þ kPðdI þ kI þ gÞÞ
q
 g dI  dP
!
; ð2:16Þ
where only the positive root allows for invasion. Indeed,
one can see that in the limit where g goes to infinity
and the delay disappears, the expression simplifies to
the expected r ¼ kP. The true intracellular delay has
been found to last for about 24 h [16,24,30]. We validated
the analytical solution with numerical simulations of a
virus dynamics model that includes an intracellular
delay and CD4þ target cells to account for a density-
dependent infection rate. Because the CD4þ target cells
are close to steady-state when the escape variant replaces
the wild-type virus, we obtained a similar escape rate as
given by equation (2.16) (results not shown).3. RESULTS
(a) HIV dynamics with multiple infections of cells
To study the impact of multiple-infected cells on the
dynamics of immune escape in HIV, we follow the evol-
ution of an escape variant during the time course of an
infection. The escape variant is considered to evade rec-
ognition of a single CTL response that kills wild-type
infected cells at a rate of 0.1 per day, i.e. a CTL response
that accounts for 10 per cent of the total death rate of
infected cells. We assume that the host is initially infected
only with wild-type virus. In a model without multiple
infection of cells, the escape variant is generated through
mutation and replaces the wild-type virus around 1 year
after infection (figure 2a). The rate at which the escape
variant replaces the wild-type, i.e. the escape rate, is
determined by the loss in CTL-mediated killing, k and
the fitness cost, c [7]. Assuming 10 per cent of the
infected cells to be co-infected with a second virus
( f ¼ 0:1) results in a disadvantage for the escape variant
and the rate of escape slows down (figure 2b). Impor-
tantly, the time until the frequency of the escape variant
is high enough to be detected by a conventional assay
(5–10%) is being delayed substantially. Furthermore,
increasing the fraction of multiple-infected cells ( f ¼
0.15) results in a threshold, where the escape variant
does not become selected anymore (figure 2c). Because
the escape variant carries a fitness cost and frequently
infects cells that are also infected with the wild-type
virus, the advantage of evading CTL-mediated killing is
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Figure 2. Selection of immune escape variants during HIV
infection. (a) If cells are not multiple-infected ( f ¼ 0.0),
then the escape variant (black) replaces the wild-type virus
(grey) 1 year after infection. (b) If 10% of the infected cells
are double-infected ( f ¼ 0.1), then the emergence of the
immune escape variant is being delayed. (c) At highermultipli-
cities of infection ( f ¼ 0.15), some escape variants cannot
become selected anymore because they suffer from an initial
growth advantage. Virus is represented as thick solid lines,
single-infected cells are shown as thin solid lines and double-
infected cells are given as thin dashed (if they carry wild-type
or escape virus only) or thin dotted lines (if they carry
wild-type and escape virus). At the bottom of each panel, the
escape variant is expressed as a frequency of the total viral
population. Infection starts with wild-type virus (Vw(0) ¼ 0)
when the CD4þ target cells are at steady-state (T(0) ¼ 3 
108), the escape variant arises by mutation with probability
m ¼ 3  1025. In all simulations: d ¼ 0.9 d21, k ¼ 0.1 d21
and c ¼ 0.085.
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Through continuous mutation, the escape variant can
be held only in a mutation–selection balance [9].
For these natural parameters, we find three different
behaviours. If cells are not multiple-infected, then theProc. R. Soc. B (2012)escape variant replaces the wild-type rapidly when the
loss in CTL-mediated killing, k, outweighs the negative
effect of the fitness cost, c. Increasing the fraction of mul-
tiple-infected cells delays the appearance of escape
variants, and slows down the rate of escape. Above a criti-
cal fraction of multiple-infected cells, the escape variant
cannot become selected anymore, because the escape
variant most often infects cells that are also infected
with wild-type virus, and the advantage of escaping
CTL-mediated killing diminishes.(b) Emergence of immune escape
In §3a, we found that multiple-infected cells can delay
and slow down the emergence of immune escape in
HIV. To investigate the dynamics of escape over a wider
parameter regime, we calculate the time until an escape
variant replaces the wild-type virus, i.e. the time when
the escape variant breaches a frequency of 50 per cent
of the total viral population (figure 3a). Given a certain
killing rate k, the contour lines indicate that the time of
appearance of the immune escape variant is being pro-
longed with an increasing frequency of multiple-infected
cells. Assuming no fitness cost, we find only substantially
longer delays if killing rates are low and the frequency of
multiple-infected cells is high (more than 50%). A similar
trend can be observed for the escape rate that we define as
the rate at which the two variants replace each other at
equal frequency (Ve ¼ Vw; figure 3b). In figure 2c, we
have already illustrated that further increasing the fraction
of multiple-infected cells can result in a threshold above
which some escape variants cannot become selected any-
more. To investigate this behaviour in more detail, we
study the appearance of immune escape for a given killing
rate, k, as a function of the fraction of multiple-infected
cells, f and the fitness cost, c. Given a low-fitness cost, the
threshold above which the escape variant does not
become selected lies at high frequencies of multiple-
infected cells (figure 3c, area above threshold). However,
if the effect of the fitness cost approaches the advantage
entailed by the immune escape, e.g. c ¼ 0.085 and k ¼
0.1, then even low fractions of multiple-infected cells can
prevent the escape variant to replace the wild-type virus.
This phenomenon resembles a process of frequency-
dependent selection that is known in ecology as the
Allee effect [35,36]. In a selection process, where the fit-
ness of an individual is correlated with its population size
or frequency, invasion or outgrowth of a population var-
iant can be prevented. In our case, multiple-infected
cells contain different virus variants proportional to
their frequency in the population. The escape virus can
fully exploit its selective advantage only if it is not co-
infected or co-infects a cell that is already infected with
an escape variant. However, at low frequencies of the var-
iant, it rarely happens that two escape variants infect the
same cell to benefit together from the loss in CTL-
mediated killing. Rather, cells that harbour the escape
variant tend to be co-infected with the wild-type virus
and the selective advantage is diminished. This phenom-
enon suggests that the initial frequency of the escape
variant determines whether it can outgrow the wild-type
virus or not. If the escape variant were present at a
higher frequency, e.g. when a patient is infected with a
virus strain that already contains the escape mutation,
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Figure 3. Timing and rate of immune escape during HIV infection. (a) Time to replacement. Increasing the fraction of multiple-
infected cells increases the time until the escape variant replaces the wild-type variant (Ve. Vw) for any killing rate k. (b) Escape
rate. A higher multiplicity of infection slows down the escape rate, i.e. the replacement rate of the two variants when Ve ¼ Vw. (c)
Time to replacement with fitness cost. Multiple infection of cells results in a threshold that prevents an escape variant,
given a certain fitness cost, to replace the wild-type virus. In (a) and (b), we conservatively assume no fitness cost. In (c), we
set k ¼ 0.1 d21.
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escape variants, and outgrowth of the variant would
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Figure 4. Escape rate as a function of the killing rate. If
cytotoxic T lymphocyte (CTL)-mediated killing occurs
during the intracellular eclipse phase and the phase of virus
production (kI ¼ kP), the escape rate directly corresponds to
the killing rate (solid line). The intracellular delay decreases
the rate of escape if killing only occurs during the stage of
virus production (kI ¼ 0, dashed line). CTL-mediated killing
might also occur only during the intracellular eclipse phase
(kP ¼ 0). This again results in an escape rate that is lower
than the killing rate (dotted line). The escape rate as a function
of the killing rate is calculated according to equation (2.16). In
all three cases, we set g ¼ 1.0 per day and assume that the
maximal death during both stages is 1.0 per day, i.e. dI þ
kI ¼ 1.0 d21 and dP þ kP ¼ 1.0 d21.(c) Intracellular delay and the rate of escape
The escape rate can be expressed as the difference in the
net growth rate between an escape variant and the wild-
type virus it replaces. Let us consider a simple case
where a population of wild-type virus competes with a
population of an escape variant that is not killed by a
specific CTL clone at a rate k. Assuming no fitness cost
of the escape variant, the escape rate should equal to
the killing rate, k [7]. However, more detailed models of
HIV dynamics that include an intracellular delay before
an infected cell starts to produce viral particles critically
affect the viral generation time and therefore the growth
rate of the virus [24].
We illustrate the effect of an intracellular delay on the
escape rate with three different examples (figure 4). Split-
ting the HIV-infected cells into an ‘early’ stage during the
intracellular eclipse phase and a ‘late’ stage of virus pro-
duction allows us to vary the death rates and the killing
rates during different stages of an infected cell. Different
CTL clones have indeed been found to induce killing of
infected cells early or late during the viral life cycle
[37]. The traditional concept is that once viral proteins
are expressed, the infected cells can be recognized and
killed by CTLs. If viral protein expression is linked to
the release of viral particles, then the infected cells
during the intracellular delay would not be prone to
CTL-mediated killing, and we call this case ‘late’ killing
(kI ¼ 0). On the other hand, HIV-infected cells have
been found to be recognized and killed by CTLs very
early after infection of a cell [38–40]. In addition, HIV
can downregulate major histocompatibility complex
(MHC)-I molecules which could prevent the ‘late’ stage
from being a target for killing (e.g. kP ¼ 0) [41]. Such a
mechanism can serve as an explanation for recent exper-
iments that have shown that CTLs do not substantially
contribute to the clearance of cells during the virus-
producing stage [42,43]. We attempt to make a fair
comparison between the two stages by restricting the
total death rate at each stage to reflect the death rate ofProc. R. Soc. B (2012)infected cells that is observed during antiretroviral
drug treatment (dI þ kI ¼ 1:0 d1 and dP þ kP ¼ 1:0 d1;
[24]). Note that this is a conservative comparison because
the death rates during the early stage can be much higher,
and still predict the conventional downslope observed
during antiretroviral drug treatment [44].
Killing rates are usually estimated using mathematical
models without an intracellular delay where it is assumed
that the escape rate reflects the killing of virus-producing
cells [7,45]. In our model with an intracellular delay, we
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virus production (kI ¼ 0 and kP . 0), then the escape
rate is expected to be lower than the killing rate kP
(figure 4, dashed line). In the case when killing occurs
during both stages of an infected cell (kI ¼ kP . 0), the
escape rate is equal to the killing rate (r ¼ kI ¼ kP, solid
line). Finally, when killing is restricted to the intracellular
delay (kI . 0 and kP ¼ 0), the escape rate is lower than
the killing rate kI but higher than what one would
expect from looking only at the killing of virus-producing
cells (dotted line).
The different relation between the killing rate and the
escape rate in our model can be explained by the different
impact of CTL-mediated killing on the lifespan of
an infected cell. If killing occurs during both stages
of an infected cell, then the killing rate directly affects
the whole lifespan. In the case when killing targets only
infected cells during the intracellular delay, or during
the stage of virus production, the impact of CTL-
mediated killing on the total lifespan of an infected cell
is smaller. Because the average lifespan of an infected
cell can directly correspond to the viral generation time
[24], the different killing regimes will be reflected in the
net growth rate of the virus and are eventually reflected
in the rate of escape. Note that the time at which the
escape variant replaces the wild-type virus is also directly
determined by the difference in the net growth rate of the
viruses, i.e. the rate of escape.4. DISCUSSION
In this study, we used mathematical modelling to investi-
gate how specific properties of the viral life cycle affect
the dynamics of immune escape in HIV. First, we find
that with increasing frequency of multiple-infected cells,
the appearance of escape variants is being delayed and
slowed down. Although the effect is weak at low frequen-
cies of multiple-infected cells, we find another interesting
property. Multiple-infected cells can prevent the escape
variant replacing the wild-type virus if the variant is associ-
ated with a fitness cost that would otherwise allow the
variant to become selected in the absence of multiple-
infected cells. Second, we study the effect of an intracellu-
lar delay before the cell starts to produce viral particles on
the rate of immune escape. We find that the escape rates
can be substantially lower than what would be expected
from the killing rate if CTL-mediated killing is induced
only during one of the stages. These findings are important
as it is generally considered that the rate at which immune
escape variants replace the wild-type virus provides infor-
mation about the selection pressure of a single CTL
clone. However, our study shows that the relation between
the escape rate and the killing rate of a CTL response is
intricate and critically depends on characteristic properties
of the HIV life cycle.
The finding that escape rates are generally slow [7] and
other observations [42,43] have lead to a controversy in
the field as to what extent CTLs are important in control-
ling HIV replication [44,46–48]. Our results provide
some insights into this ongoing debate as we show that
slow escape rates do not necessarily imply a weak selec-
tion pressure of CTL clones. Together with the findings
from a previous study [9], we identified four factors that
can affect the observed rates of escape in HIV-infectedProc. R. Soc. B (2012)patients: the fitness cost of the escape mutation, multiple
infection of cells, intracellular delays and the estimation
bias caused by infrequent sampling. While multiple-
infected cells only moderately slow down the rate of
immune escape, we have shown here and elsewhere [9]
that the other three factors can easily result in a twofold
difference between the killing rate in vivo and the
observed escape rate. However, it remains difficult to
quantify the relative contribution of these factors on
escape rates. For example, the rapid reversion of escape
variants during acute infection when the infected cell
turnover is high could result in an overestimation of fit-
ness costs during the chronic phase of infection [8].
Nevertheless, our results suggest that if escape rates are
estimated to be around 0.01 per day [7], it could well
be that this reflects the immune escape from a CTL
clone that is eliminating infected cells at a higher rate.
Because there is generally a broad cellular immune
response against HIV, CTL-mediated killing through
different clones could potentially account for a substantial
amount of the infected cell death, especially if killing hap-
pens during the intracellular eclipse phase [44]. For broad
immune responses, the escape rates from individual CTL
clones will be even slower if the killing rate of individual
target cells saturates for high densities of CTLs specific
for the various epitopes expressed by that target, or if
the total CTL density is determined by competition [6].
In such a scenario, the total killing rate will hardly
decrease if the virus escapes from only one of the several
responses. Thus, although the escape rate from each of
the CTL responses may be exceedingly slow, these
responses could together provide strong immune control.
Given the discrepancy between the multiplicity of
infection that has been found in the spleen [11] and the
peripheral blood [19], we cannot clearly say how strong
an effect of multiple-infected cells on immune escape in
HIV is to be expected. The proviruses that were found
in CD4þ T cells of the peripheral blood were found to
be genetically similar to the circulating virus in the
plasma [19], indicating that they represent the replicating
virus population. On the other hand, the majority of HIV-
infected cells reside in lymph nodes and the spleen [49],
but it remains unclear whether the multiply infected sple-
nocytes in the study from Jung et al. [11] represent
productively infected cells that contribute to ongoing
virus replication.
Our findings are based on the assumption that a sec-
ondary infection of a cell occurs at random and does
not depend on the virus that infected the cell first.
Whereas this assumption might be valid for a well-
mixed system such as the peripheral blood, the situation
in the lymphoid tissue is likely to be different. Studies
have shown that HIV can exhibit spatially distributed
meta-population dynamics within an infected host,
which suggests a non-random distribution of the viral
quasi-species [50–52]. Specifically, cells in close proxi-
mity could infect each other through cell-to-cell
transmission [16,18,53]. If that were the case, the pro-
viruses in multiple-infected cells would most often
derive from the same cell and therefore be of the same
type. As long as escape variants are often co-infected
with the same escape variant, the intrinsic disadvantage
of multiple infections does not occur. However, the
study by Jung et al. [11] showed that the numerous
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suggesting that they possibly encode for wild-type and
escaped epitopes.
Finally, we assume that cells that are infected with
wild-type virus and the escape variant experience the
same killing rate as cells that are infected only with
wild-type virus. This seems a reasonable assumption if
the escaped epitope evades presentation on the cell sur-
face, or if the density of wild-type epitopes on the cell
surface is not a limiting factor. If the mutant epitope is
presented by the same MHC molecule, but is not recog-
nized by any CTLs, then the killing rate could be reduced
due to competition with wild-type epitopes for MHC
molecules presented on the cell surface. Because CTLs
can recognize and kill target cells presenting very few epi-
topes on the cell surface [54], this competition need not
be important and our assumption would seem fair.
In summary, both of our models suggest that the late
appearance of escape variants and the slow replacement
of the wild-type virus do not necessarily indicate ineffi-
cient CTL-mediated killing of HIV-infected cells. The
characteristic dynamics might at least partly be a result
of specific properties of the HIV life cycle, challenging
the view that the rate of immune escape directly reflects
the rate at which infected cells are killed by CTLs.
Although escape rates are usually found to be slow, our
conjecture is that CTLs could play an important role in
controlling viral infections such as HIV and induce a
strong selection pressure on the viral population.We thank two anonymous reviewers for their helpful
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